Patents by Inventor Keryn Johnson

Keryn Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170190748
    Abstract: The present disclose relates to anti-inflammatory proteins/peptides, their uses, methods of preparation and methods of their detection. In particular, the invention relates to major royal jelly proteins modified by methyglyoxal and fragments thereof from a Leptospermum derived honey and royal jelly.
    Type: Application
    Filed: January 11, 2017
    Publication date: July 6, 2017
    Inventors: Keryn JOHNSON, Cynthia SUN, Ulrike HUBL, Jaganmohan BILLAKANTI
  • Patent number: 9580464
    Abstract: Anti-inflammatory proteins/peptides are described, as well as their uses, methods of preparation, and methods of their detection. Specifically described are major royal jelly proteins modified by methylglyoxal and fragments thereof from a Leptospermum derived honey and royal jelly.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: February 28, 2017
    Assignee: MANUKAMED HOLDINGS LIMITED PARTNERSHIP
    Inventors: Keryn Johnson, Cynthia Sun, Ulrike Hubl, Jaganmohan Billakanti
  • Publication number: 20150337019
    Abstract: The present disclose relates to anti-inflammatory proteins/peptides, their uses, methods of preparation and methods of their detection. In particular, the invention relates to major royal jelly proteins modified by methylglyoxal and fragments thereof from a Leptospermum derived honey and royal jelly.
    Type: Application
    Filed: June 24, 2013
    Publication date: November 26, 2015
    Applicant: ManukaMed Limited
    Inventors: Keryn JOHNSON, Cynthia SUN, Ulrike HUBL, Jaganmohan BILLAKANTI
  • Patent number: 8404644
    Abstract: The invention relates to the use of angiogenic crystallin proteins to promote angiogenesis, wound healing and/or endothelial cell migration. Alpha A crystallin and ?B2 crystallin have particular application in these methods. The crystallins will usually be in monomeric form. Typically, truncated form(s) of ?B2 crystallin protein are utilized as can be prepared by partial hydrolysis of the protein by a protease enzyme such as elastase I. Methods for the purification of crystallin proteins from eye tissue are also described.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: March 26, 2013
    Assignees: Meat & Livestock Australia Limited, Industrial Research Limited
    Inventors: Keryn Johnson, Madhusudan Vasudevamurthy
  • Publication number: 20100210531
    Abstract: The invention relates to the use of angiogenic crystallin proteins to promote angiogenesis, wound healing and/or endothelial cell migration. Alpha A crystallin and ?B2 crystallin have particular application in these methods. The crystallins will usually be in monomeric form. Typically, truncated form(s) of ?B2 crystallin protein are utilized as can be prepared by partial hydrolysis of the protein by a protease enzyme such as elastase I. Methods for the purification of crystallin proteins from eye tissue are also described.
    Type: Application
    Filed: September 5, 2008
    Publication date: August 19, 2010
    Inventors: Keryn Johnson, Madhusudan Vasudevamurthy